[Changes in the number of suicide attempts in the NPC region since the start of VigilanS: First estimates].

Évolutions du nombre de tentatives de suicide dans le Nord-PasdeCalais depuis l’implantation de VigilanS : premières estimations.

Journal

L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 23 08 2018
revised: 03 09 2018
accepted: 08 09 2018
pubmed: 25 11 2018
medline: 3 8 2019
entrez: 25 11 2018
Statut: ppublish

Résumé

The implementation of a surveillance program after a suicide attempt (SA) is a very innovative step in the evolution of our system of care. It was interesting to know if we observe a decline in suicide attempts in the region, in particular of recurrences of SA. We measured the evolution of the number of suicide attempts before and after implantation of VigilanS, using two types of analysis: a first from the national medical information systems in Medicine-Surgery-Obstetrics (PMSI-MCO) and a second from the collection of the ER stays for SA in the hospitals involved in the VigilanS program. In 2014 (year before start of VigilanS), a total of 10 119 ER stays for SA was observed (5626 women and4463 men); in 2017, the total was 9.230 stays for SA (5047 women and 3 839 men), representing a decrease of 13.5%. The reduction was balanced between men (-14%) and women (-10%). Based on the figures of PMSI, we see an acceleration of the reduction of stay for SA in the Nord-Pas-de-Calais after 2014 (-16% instead of -6%), instead of the two Picardy departments the most comparable which show a degradation of the phenomenon (+13%), and opposed to the Department of the Oise which shows a stable maintenance of the current decline (-12%). These two indicators are imperfect, but evolution over three years since the implementation of VigilanS goes in the same direction. We find a uncoupling of a hospital stay in connection with a SA. The intensity of this decline seems correlated to the penetrance of the program.

Sections du résumé

BACKGROUND BACKGROUND
The implementation of a surveillance program after a suicide attempt (SA) is a very innovative step in the evolution of our system of care. It was interesting to know if we observe a decline in suicide attempts in the region, in particular of recurrences of SA.
METHOD METHODS
We measured the evolution of the number of suicide attempts before and after implantation of VigilanS, using two types of analysis: a first from the national medical information systems in Medicine-Surgery-Obstetrics (PMSI-MCO) and a second from the collection of the ER stays for SA in the hospitals involved in the VigilanS program.
RESULTS RESULTS
In 2014 (year before start of VigilanS), a total of 10 119 ER stays for SA was observed (5626 women and4463 men); in 2017, the total was 9.230 stays for SA (5047 women and 3 839 men), representing a decrease of 13.5%. The reduction was balanced between men (-14%) and women (-10%). Based on the figures of PMSI, we see an acceleration of the reduction of stay for SA in the Nord-Pas-de-Calais after 2014 (-16% instead of -6%), instead of the two Picardy departments the most comparable which show a degradation of the phenomenon (+13%), and opposed to the Department of the Oise which shows a stable maintenance of the current decline (-12%).
CONCLUSION CONCLUSIONS
These two indicators are imperfect, but evolution over three years since the implementation of VigilanS goes in the same direction. We find a uncoupling of a hospital stay in connection with a SA. The intensity of this decline seems correlated to the penetrance of the program.

Identifiants

pubmed: 30470501
pii: S0013-7006(18)30200-8
doi: 10.1016/j.encep.2018.09.006
pii:
doi:

Types de publication

Journal Article

Langues

fre

Pagination

S22-S26

Informations de copyright

Copyright © 2018. Published by Elsevier Masson SAS.

Auteurs

G Vaiva (G)

SCA-Lab UMR 9193 CNRS, pôle de psychiatrie, médecine légale et médecine en milieu pénitentiaire, CHU de Lille, université de Lille, rue André-Verhaeghe, 59037 Lille, France. Electronic address: guillaume.vaiva@chru-lille.fr.

L Plancke (L)

Centre lillois d'études sociologiques et économiques, fédération régionale de recherche en psychiatrie et santé mentale Hauts-de-France, 59037 Lille, France.

A Amariei (A)

Centre lillois d'études sociologiques et économiques, fédération régionale de recherche en psychiatrie et santé mentale Hauts-de-France, 59037 Lille, France.

A L Demarty (AL)

Inserm, Fédération de recherche clinique, CHU de Lille, 59037 Lille, France.

M Lardinois (M)

Service universitaire de psychiatrie, CHU de Versailles, 78000 Versailles, France.

A Creton (A)

Service de psychiatrie, centre hospitalier de Valenciennes, France.

C Debien (C)

SCA-Lab UMR 9193 CNRS, pôle de psychiatrie, médecine légale et médecine en milieu pénitentiaire, CHU de Lille, université de Lille, rue André-Verhaeghe, 59037 Lille, France.

S Duhem (S)

Inserm, Fédération de recherche clinique, CHU de Lille, 59037 Lille, France.

A Messiah (A)

Inserm U-1178, mental health and public health, hôpital Paul-Brousse, 94800 Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH